Search results for " Control"

showing 10 items of 7691 documents

Associations between type of treatment and illness-specific locus of control in type 1 diabetes patients

1993

Abstract This study examined differences in diabetes-specific locus of control beliefs of 82 insulin-treated Type I diabetes patients undergoing either conventional therapy (CT), intensified conventional therapy (ICT) or continuous subcutaneous insulin infusion (CSII). Compared to CT with its adherence to a strict regimen, ICT and CSII allow a much greater flexibility in timing of meals and daily activities. On the other hand, such flexibility requires a much more active role of the patient. The hypotheses of higher internality and lower powerful others locus of control beliefs in ICT and CSII patients than in CT patients could be supported for powerful others locus of control only. A one-y…

medicine.medical_specialtyType 1 diabetesActivities of daily livingbusiness.industrymedia_common.quotation_subjectPublic Health Environmental and Occupational HealthFlexibility (personality)General MedicineGeneral Chemistrymedicine.diseaseSurgerySubcutaneous insulinRegimenLocus of controlInternal medicinemedicinePersonalityPoor glycaemic controlbusinessApplied Psychologymedia_commonPsychology & Health
researchProduct

A noninvasive postoperative clinical score to identify patients at risk for postoperative pulmonary complications: The air-test score

2020

BACKGROUND: Postoperative pulmonary complications (PPCs) negatively affect morbidity, healthcare costs and postsurgical survival. Preoperative and intraoperative peripheral oxyhemoglobin saturation (SpO2) levels are independent risk factors for postoperative pulmonary complications (PPCs). The air-test assesses the value of SpO2 while breathing room-air. We aimed at building a clinical score that includes the air-test for predicting the risk for PPCs. METHODS: This is a development and validation study in patients -randomly divided into two cohorts- from a large randomized clinical trial (iPROVE) that enrolled 964 intermediate-to-high risk patients scheduled for abdominal surgery. Arterial …

medicine.medical_specialtyValidation studyPulmonary AtelectasisAtelectasisRisk Assessmentlaw.inventionCohort Studies03 medical and health sciencesPostoperative pulmonary atelectasis0302 clinical medicinePostoperative ComplicationsRandomized controlled trial030202 anesthesiologylawRisk FactorsmedicineHumansPredictive value of testDerivationLungReceiver operating characteristicbusiness.industryfungi030208 emergency & critical care medicinemedicine.diseaseSurgeryRespiratory Function TestsPostoperative complicationAnesthesiology and Pain MedicineTest scoreCohortbusinessAbdominal surgery
researchProduct

Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis

1994

Between 1988 and 1990 an unblinded, randomized trial of terlipressin or vasopressin plus transdermal nitroglycerin, as part of a treatment strategy including emergency sclerotherapy for actively bleeding varices, was conducted during 165 admissions in 137 patients with cirrhosis and upper digestive bleeding. Eighty-four patient admissions were assigned to terlipressin (2 mg every 6 h) and 81 to vasopressin (0.4 to 0.8 unit per min) plus transdermal nitroglycerin (20 to 80 mg). The two groups were comparable for relevant clinical data, but there were slightly more patients with hepatocellular carcinoma or terminal conditions in the terlipressin group. After the 24-h study period, failure to …

medicine.medical_specialtyVasopressinCirrhosisHepatologybusiness.industrymedicine.medical_treatmentmedicine.diseaseSurgerylaw.inventionDiscontinuationRandomized controlled triallawAnesthesiamedicineSclerotherapyUpper gastrointestinal bleedingbusinessTerlipressinVaricesmedicine.drugJournal of Hepatology
researchProduct

Diagnosis and Treatment of Lower Extremity Venous Thromboembolism

2020

Importance: Incidence rates for lower extremity deep vein thrombosis (DVT) range from 88 to 112 per 100 000 person-years and increase with age. Rates of recurrent VTE range from 20% to 36% during the 10 years after an initial event.Observations: PubMed and Cochrane databases were searched for English-language studies published from January 2015 through June 2020 for randomized clinical trials, meta-analyses, systematic reviews, and observational studies. Risk factors for venous thromboembolism (VTE), such as older age, malignancy (cumulative incidence of 7.4% after a median of 19 months), inflammatory disorders (VTE risk is 4.7% in patients with rheumatoid arthritis and 2.5% in those withou…

medicine.medical_specialtyVena Cava FiltersDeep vein01 natural sciencesPostthrombotic Syndromelaw.inventionFibrin Fibrinogen Degradation Products03 medical and health sciencesSex Factors0302 clinical medicineRandomized controlled trialPredictive Value of TestsRisk FactorslawInternal medicineMedical IllustrationFactor V LeidenHumansThrombophiliaMedicineCumulative incidencecardiovascular diseases030212 general & internal medicine0101 mathematicsLife StyleThrombectomyUltrasonographybusiness.industry010102 general mathematicsAge FactorsWarfarinVenous ThromboembolismGeneral Medicinemedicine.diseaseThrombosisPre- and post-test probabilitymedicine.anatomical_structureLower ExtremityPredictive value of testsWarfarinSymptom AssessmentbusinessBiomarkersFactor Xa Inhibitorsmedicine.drugJAMA
researchProduct

Reperfusion of liver graft during transplantation: techniques used in transplant centres within Eurotransplant and meta-analysis of the literature

2013

Abstract: It remains unclear which liver graft reperfusion technique leads to the best outcome following transplantation. An online survey was sent to all transplant centres (n=37) within Eurotransplant (ET) to collect information on their technique used for reperfusion of liver grafts. Furthermore, a systematic review of all literature was performed and a meta-analysis was conducted based on patients' mortality, number of retransplantations and incidence of biliary complications, depending on the technique used. Of the 28 evaluated centres, 11 (39%) reported performing simultaneous reperfusion (SIMR), 13 (46%) perform initial portal vein reperfusion (IPR), 1 (4%) performs an initial hepati…

medicine.medical_specialtyVena cavamedicine.medical_treatmentPortal veinMedizin030230 surgeryRevascularizationVenovenous bypassretrograde reperfusionlaw.invention03 medical and health sciences0302 clinical medicineHepatic ArteryRandomized controlled triallawSurveys and QuestionnairesMedicineHumansRandomized Controlled Trials as TopicTransplantationbusiness.industryPortal Veinsimultaneous reperfusion3. Good healthSurgeryLiver TransplantationTransplantationLiver graftEuropeTreatment OutcomeMeta-analysisReperfusion030211 gastroenterology & hepatologyHuman medicineliver reperfusionbusinesssequential reperfusionLiver Circulation
researchProduct

Mitigando el dolor durante la punción venosa en una población pediátrica: un estudio factorial aleatorizado

2016

medicine.medical_specialtyVenipuncturebusiness.industryMEDLINEGeneral MedicineFactorial experimentPhlebotomylaw.inventionProcedural Pain03 medical and health sciences0302 clinical medicineRandomized controlled triallawPhysical therapymedicine030212 general & internal medicinebusiness030217 neurology & neurosurgeryGeneral NursingPediatric populationEnfermería Clínica
researchProduct

Accumulation of sensory difficulties predicts fear of falling in older women

2013

Objectives: To explore whether the accumulation of sensory difficulties predicts fear of falling (FOF), and whether the traits correlate with each other regardless of familial factors. Methods: Self-reported hearing, vision and balance difficulties, and FOF were assessed using structured questionnaires at the baseline and after a 3-year follow-up in 63- to 76-year-old women ( n = 434). Results: Among the women without FOF at baseline ( n = 245), 41% reported FOF at follow-up. Increasing numbers of sensory difficulties at baseline predicted higher incidence of FOF. The relationship between accumulated sensory difficulties and FOF was not mediated by familial factors. Discussion: The accumul…

medicine.medical_specialtyVision DisordersPoison controlSensory systemAudiologyFear of fallingSuicide preventionOccupational safety and health03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesInjury preventionHumansMedicine030212 general & internal medicine10. No inequalityHearing DisordersPostural BalanceAgedBalance (ability)Community and Home Carebusiness.industryHuman factors and ergonomicsta3141FearMiddle AgedSensation DisordersPhysical therapyAccidental FallsFemaleGeriatrics and Gerontologymedicine.symptombusinessGerontology030217 neurology & neurosurgeryFollow-Up StudiesJournal of aging and health
researchProduct

Intravitreal Dexamethasone Implant for Postoperative Macular Oedema Secondary to Vitrectomy for Epiretinal Membrane and Retinal Detachment: A Systema…

2021

Purpose. To evaluate the efficacy of intravitreal dexamethasone implant (DEX) for the treatment of macular oedema secondary to vitrectomy for epiretinal membrane (ERM) and retinal detachment (RD) by conducting a systematic review with meta-analysis of published studies. Methods. Studies reporting clinical outcomes of DEX use for the treatment of macular oedema secondary to ERM and RD vitrectomy were searched on PubMed and Embase databases. The primary outcome was best-corrected visual acuity (BCVA) change between baseline and post-DEX treatment, reported as mean difference (MD) with 95% confidence interval (CI). Mean central macular thickness (CMT) change was assessed as a secondary outcome…

medicine.medical_specialtyVisual acuitygenetic structuresmedicine.medical_treatmentPopulationVitrectomyReview Articlelaw.inventionRandomized controlled triallawOphthalmologymedicineeducationDexamethasoneeducation.field_of_studybusiness.industryRetinal detachmentRE1-994medicine.diseaseConfidence intervalmacular oedema intravitreal dexamethasone implant (DEX) vitrectomy epiretinal membrane (ERM) retinal detachment (RD).OphthalmologyEpiretinal membranemedicine.symptombusinessmedicine.drug
researchProduct

Efficacy of the photobiomodulation therapy in the treatment of the burning mouth syndrome

2019

Background This study aims to evaluate the efficacy of the photobiomodulation therapy (PBMT) - in terms of pain and of quality of life- in patients affected by burning mouth syndrome (BMS). Material and Methods This study was designed as a randomised double-blinded prospective study. Patients diagnosed with BMS in the period from June 2015 to June 2018 were recruited. The patients were randomised into two groups and each received treatment once a week for ten weeks: group A received laser therapy (K Laser Cube 3®) while group B was given sham therapy (placebo). Pain was evaluated through the Visual Analogue Scale (VAS) and quality of life was assessed with the short form of the Oral Health …

medicine.medical_specialtyVisual analogue scaleBurning Mouth SyndromeOral healthPlaceboGroup Blaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialQuality of lifelawSurveys and QuestionnairesInternal medicineHumansMedicineProspective StudiesLow-Level Light TherapyProspective cohort studyGeneral DentistryOral Medicine and Pathologybusiness.industryResearch030206 dentistryBurning mouth syndrome:CIENCIAS MÉDICAS [UNESCO]OtorhinolaryngologyUNESCO::CIENCIAS MÉDICASQuality of LifeSurgerymedicine.symptombusiness
researchProduct

Photobiomodulation therapy for the management of recurrent aphthous stomatitis in children : clinical effectiveness and parental satisfaction

2020

Background This study aims to evaluate the effectiveness of the photobiomodulation therapy (PBMT) in the treatment of minor recurrent aphthous stomatitis (MiRAS) in children, in terms of pain relief, lesion size reduction and the parental satisfaction of the therapy. Material and Methods This randomized controlled study was carried out on 60 children with clinical diagnosis of MiRAS. Patients were randomized into two groups: group A receiving laser therapy and group B receiving sham therapy (placebo). Laser therapy (diode laser, λ: 645 nm) was administered on day 1 (T0) for three consecutive days. Patients were evaluated also on day 4 (T1), on day 7 (T2) and on day 10 (T3). Oral aphthous le…

medicine.medical_specialtyVisual analogue scaleChildren; Lasers; UlcersPersonal SatisfactionPlaceboRecurrent aphthous stomatitisPeriodontal probeGroup Blaw.inventionLesion03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicinemedicineHumansLow-Level Light TherapyChildChildrenGeneral DentistryStomatitisPain MeasurementUlcersOral Medicine and Pathologybusiness.industryResearchLasers030206 dentistrymedicine.disease:CIENCIAS MÉDICAS [UNESCO]Treatment OutcomeOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASStomatitis AphthousSurgerymedicine.symptombusiness
researchProduct